pact of hepatitis C infection on outcomes after heart transplantation. Transplantation 2009; 88: 1137. 3. Lee I, Localio R, Brensinger CM, et al. Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity. J Heart Lung Transplant 2011; 30: 1266. 4. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975. 5. Fagiuoli S, Pevere S, Minniti F, et al. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients. Transplantation 2003; 75: 982. 6. Kim EY, Ko HH, Yoshida EM. A concise review of hepatitis C in heart and lung transplantation. Can J Gastroenterol 2011; 25: 445. 7. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuousflow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 20: S1.
Arvind Menon合作论文数2
Sharma Vijay Kumar合作论文数Yong Loo Lin School of Medicine, National University of Singapore2
Darshana M Dadhania合作论文数Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University2Ponce Blanca合作论文数2Rex Friedlander合作论文数2
Manikkam Suthanthiran合作论文数Weill Cornell Medicine, Cornell University;Department of Transplantation Medicine, The New York-Presbyterian-Weill Cornell Medical Center;Division of Nephrology and Hypertension, The New York-Presbyterian-Weill Cornell Medical Center2
Thangamani Muthukumar合作论文数Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University1Prabhakar Putheti合作论文数Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University1
